Form 8-K - Current report:
SEC Accession No. 0001213900-22-050070
Filing Date
2022-08-22
Accepted
2022-08-22 16:30:42
Documents
12
Period of Report
2022-08-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea164724-8k_abvcbio.htm   iXBRL 8-K 24044
  Complete submission text file 0001213900-22-050070.txt   194066

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20220819.xsd EX-101.SCH 2965
3 XBRL LABEL FILE abvc-20220819_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abvc-20220819_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT ea164724-8k_abvcbio_htm.xml XML 3492
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 221184081
SIC: 2834 Pharmaceutical Preparations